Norwest
Venture capital
UncertainLast verified 7 Nov 2026
Norwest is a global venture capital and growth equity firm investing from early stage to late-stage growth across biotech, life sciences, fintech, proptech, consumer, and B2B SaaS.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Biotech & pharma, Fintech, Proptech & construction, B2B SaaS
- Eligible countries
- Not stated
- Provider based in
- United States
- Timing
- Rolling applications
- Focus
- biotech; life sciences; fintech; proptech; consumer; B2B SaaS
- How to apply
- Warm introduction only
- Source
- https://www.norwest.com/
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
A top venture and growth equity investment firm, Norwest has backed over 700 companies
https://www.norwest.com/ - Sectors
biotech, life sciences, fintech, proptech, consumer, B2B SaaS, and more
https://www.norwest.com/ - Stages
From first check to late-stage growth, we back standout companies
https://www.norwest.com/
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Norwest? Claim this profile to confirm what you invest in.